We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hemogenyx Pharmaceuticals Plc | LSE:HEMO | London | Ordinary Share | GB00BYX3WZ24 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.084 | 7.81% | 1.16 | 1.122 | 1.198 | 1.15 | 1.122 | 1.15 | 3,575,963 | 16:35:07 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -6.69M | -0.0050 | -2.24 | 14.44M |
Date | Subject | Author | Discuss |
---|---|---|---|
14/2/2024 11:34 | Below a penny next week ! | gahi23 | |
14/2/2024 11:33 | Suckers buying this turkey in for a shock next week hahahahaha | gahi23 | |
14/2/2024 11:31 | Holding for 10p on deal with major. Massively derisked now. | gah123 | |
14/2/2024 11:07 | MM's are naked shorting the stock. Real price on imminent big pharma deal. | gah123 | |
14/2/2024 11:00 | Unbelievable trolls have arrived here as well. Very good sign | gah123 | |
14/2/2024 11:00 | Anyway, moving swiftly on.Another big volume day ahead. It's certainly forming a base at 3p which is good to see. | premium beeks | |
14/2/2024 10:57 | Below 1p next week ! Let that sink in mugs !!!!! | gahi23 | |
14/2/2024 10:56 | Mugs being sold a lemon here hahaha | gahi23 | |
14/2/2024 09:48 | https://x.com/bobsmi | stevehuges | |
14/2/2024 09:38 | They seem to be doing very well with the team that they have, why do you need more people? | ashleyjv | |
14/2/2024 09:33 | Over on X formally known as Tw*tt*R.... Rahul Patel @RahulPa94684305 #HEMO-compare MC with other pharma and products in pipeline...did you think, it need to worry with finances, lots of options open and last was raised when it was 4.5p so,can't be this price...this will rocket to 9p min and still not 300M mc [Table of industry peers] | apotheki | |
14/2/2024 09:15 | Hemogenyx Pharmaceuticals plc (LSE:HEMO) have done a brilliant job so far as a tightly [not many employees etc....] run but fast growing bio-tech company using all the modern techniques such as AI | apotheki | |
14/2/2024 09:03 | Actually to be fair the whole of the U.K. bio-tech sector is doing well at the moment I guess in some part playing catch up to our North American [USA bio-tech sector] cousins! | apotheki | |
14/2/2024 08:52 | HEMO is a one man band ans his lawyer wife. Almost no institutions on the share register. It's a pump and dump peterhouse promote. It's not the 17th century. Pharma is a serious business and breakthroughs don't come from one man bands with no financial backing. This is all about getting people short for a raise. | loglorry1 | |
14/2/2024 08:40 | You can buy the shares in the knowledge that there is now much less risk as the USA FDA have given their full blessing to Hemogenyx Pharmaceuticals plc (LSE:HEMO) In my opinion BUY the drop as the shares are on the way back up to 14p to 15p and potentially even higher. The shares [when compared to their peers] should command a MKT CAP of well in excess of £100m - most probably a few hundred million so the shares could potentially go UP to say 25p+ | apotheki | |
14/2/2024 08:34 | Yeah right! | apotheki | |
14/2/2024 08:31 | Profit moving to APH | blackhorse23 | |
14/2/2024 08:28 | We should be 6p+ easy, they can't hold us down there's too much going for it. Next update likely to be deal with major pharma. Q | gah123 | |
14/2/2024 08:25 | Another step forward for Hemo. | sharetalk | |
14/2/2024 08:25 | Following on from my last post I would NOT be surprised to see some of the following occur shortly.... MAJOR funder [perhaps as previously at a PREMIUM] Strategic partnership with a MAJOR industry player Rapid move towards Stage 2 development + Potential TAKE OVER play now?!?!? | apotheki | |
14/2/2024 08:20 | Also taken from X formally known as Tw*tt*r reference valuation comparisons with peer group.... justamantrading @justamantrading #HEMO Peer to Peer review “The average market capitalisation of the peer-group is £242m, over 7-fold higher than that of Hemogenyx “ our current MCAP [See industry table in the report below] | apotheki | |
14/2/2024 08:19 | Which means lots of catalysts | gah123 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions